PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Nov-2023 Global Multiparameter Patient Monitoring System Market to Witness Robust 5.8% CAGR Through 2031: Chronic Disease Prevalence and Technological Advancements Drive Growth - ResearchAndMarkets.com Businesswire
10-Nov-2023 FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach Businesswire
10-Nov-2023 AdaptHealth Corp. to Participate in Upcoming Investor Conferences Businesswire
10-Nov-2023 ReCode Therapeutics to Participate in November Conferences Businesswire
10-Nov-2023 Establishment Labs Announces Participation in Two Upcoming Investment Conferences Businesswire
10-Nov-2023 Astria Therapeutics Presents New Phase 1a Data Confirming Potential for STAR-0125 to Prevent Hereditary Angioedema Attacks with Dosing 2 or 4 Times Per Year at the 2023 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting Businesswire
10-Nov-2023 Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023 Businesswire
10-Nov-2023 ATCC Products to be Used in Microgravity Experiments on the International Space Station Businesswire
10-Nov-2023 Boston Pharmaceuticals Announces Positive Phase 2a Data Supporting Once-monthly Dosing With Investigational BOS-580 in NASH and Treatment Effects in Diabetic Subgroups at AASLD The Liver Meeting® 2023 Businesswire
10-Nov-2023 Immunome to Present at the Stifel 2023 Healthcare Conference Businesswire
10-Nov-2023 Global Electronic Weighing Scales Strategic Analysis Report 2023-2030 with Focus on 135+ Select Players - ResearchAndMarkets.com Businesswire
10-Nov-2023 NanoSyrinx appoints Anthony Johnson as Non-Executive Director Businesswire
10-Nov-2023 Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer Businesswire
10-Nov-2023 JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA Businesswire
10-Nov-2023 JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA Businesswire
10-Nov-2023 FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma Businesswire
10-Nov-2023 Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting Businesswire
10-Nov-2023 4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts Businesswire
10-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Nov-2023 Takeda recibe la aprobación de la FDA de EE. UU. del FRUZAQLA™ (fruquintinib) para el cáncer colorrectal metastásico previamente tratado Businesswire